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Abstract
Background: A P-type transposable element called PdL has been engineered with a doxycycline-
inducible promoter directed out through the 3 end of the element. Insertion of PdL near the
5 end of a gene often yields doxycycline-dependent overexpression of that gene and a mutant
phenotype. This functional genomics strategy allows for efficient screening of large numbers of
genes for overexpression phenotypes.
Results: PdL was mobilized to around 10,000 new locations in the Drosophila melanogaster
genome and used to search for genes that would extend life span when overexpressed. Six lines
were identified in which there was a 5-17% increase in life span in the presence of doxyxcycline.
The mutations were molecularly characterized and in each case a gene was found to be
overexpressed using northern blots. Two genes did not have previously known phenotypes and
are implicated in membrane transport: VhaSFD encodes a regulatory subunit of the vacuolar
ATPase proton pump (H+-ATPase), whereas Sugar baby (Sug) is related to a maltose permease
from Bacillus. Three PdL mutations identified previously characterized genes: filamin encodes the
homolog of an actin-polymerizing protein that interacts with presenilins. four wheel drive (fwd)
encodes a phosphatidylinositol-4-kinase (PI 4-kinase) and CTP:phosphocholine cytidylyltransferase-1
(Cct1) encodes the rate-limiting enzyme in phosphatidylcholine synthesis. Finally, an apparently
novel gene (Red herring, Rdh) was found in the first intron of the encore gene. 
Conclusions: Screening for conditional mutations that increase Drosophila life span has identified
genes implicated in membrane transport, phospholipid metabolism and signaling, and actin
cytoskeleton organization.
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Background 
Drosophila melanogaster has been a leading model for the
study of aging for over 80 years [1-5]. The intensive use of
Drosophila as a model for developmental biology has
produced a wealth of genetic and molecular biological tools
that are readily adapted to the study of aging. Aging is asso-
ciated with characteristic changes at the physiological and
molecular level, however organismal life span is still the best
Open Access
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media for any purpose, provided this notice is preserved along with the article's original URL. measure of aging rate. The most successful studies of aging
generally involve manipulations that increase life span.
Experimental alterations of environment or genetic makeup
that cause decreased life span might create novel diseases or
pathologies that do not usually limit life span in a normal
individual. In contrast, a manipulation that increases life
span is thought to be more likely to identify mechanisms
that normally limit the life span of the organism.
Laboratory selection of Drosophila populations for late-life
reproduction results in extended life span [6-8]. The genetic
selection experiments demonstrate that life span has a large
genetic component and is highly plastic. Increased life span
was generally correlated with increased stress resistance
including increased oxidative stress resistance [9,10]. An
important question in the study of aging in invertebrates is
whether life span can be increased without a trade off with
metabolic activity. Certain manipulations that decrease
metabolic activity cause increased life span, such as lower
culture temperature [11]. In the genetic selection experi-
ments, life span is increased without a reduction in meta-
bolic activity [12,13].
Single gene mutations have been identified that increase
Drosophila life span. These mutations identify negative regu-
lators of life span, as mutations expected to decrease activity
of the gene lead to increased life span. mth encodes a protein
related to G-protein coupled receptors, and appears to nega-
tively regulate life span, stress resistance and body size [14].
Indy is related to a mammalian cotransporter involved in
membrane transport of Krebs cycle intermediates, leading to
the suggestion that Indy mutations might increase life span
by decreasing the availability of nutrients [15].
Certain mutant alleles of either the Inr or the chico genes
can increase Drosophila life span [16,17]. Inr is homologous
to the mammalian insulin receptor and insulin-like growth
factor receptor, while chico is homologous to the mam-
malian insulin receptor substrate. The data indicate that an
insulin-like signaling pathway negatively regulates life
span, as had previously been found for the nematode
C. elegans [18]. This pathway for life span regulation may
be even more highly conserved during evolution, as there
are many similarities with life span regulation in mammals
and in yeast. The increased life span regulated by the
insulin-like signaling pathway in C. elegans is associated
with increased resistance to stress, including oxidative
stress [18-21]. This has led to suggestions that increased
oxidative stress resistance and decreased amounts of oxida-
tive damage may be the mechanism by which mutation of
the insulin-like signaling pathway causes increased life
span. Consistent with this idea, life-span extension in
C. elegans is associated with increased expression of the
gene encoding the mitochondrial antioxidant enzyme man-
ganese-containing superoxide dismsutase (MnSOD) [22].
In  Drosophila, mutations of chico that extend life span
increase total SOD enzyme activity; however, resistance to
oxidative stress was not detectably increased, at least not as
assayed by paraquat resistance [16]. Therefore it remains to
be determined if mutation of the insulin-like pathway in
Drosophila increases life span by increasing SOD activity or
by some other mechanism(s).
Increased life span caused by overexpression of a gene by def-
inition identifies a positive regulator of life span. Several
genes involved in oxidative stress defense have been found to
increase life span when overexpressed in transgenic flies.
These include genes for both forms of SOD, the Cu/ZnSOD
found in the cytoplasm and outer mitochondrial space, and
MnSOD found in the inner mitochondrial space [23-25].
These enzymes convert the most common oxygen radical pro-
duced by the mitochondria, superoxide, into hydrogen perox-
ide and water. Abundant catalase enzyme then converts the
hydrogen peroxide into molecular oxygen and water. Overex-
pression of Cu/ZnSOD or MnSOD increases life span up to
about 40%, and the amount of life span increase is found to
be proportional to the amount of enzyme increase in each
case. The life span increase caused by SOD overexpression is
not associated with a detectable tradeoff in metabolic activity,
as oxygen consumption was normal throughout the extended
life span of the flies [24]. Overexpression of the antioxidant
enzyme peptide methionine sulfoxide reductase is also asso-
ciated with increased life span [26]. Finally, several genes
implicated in repair and stress responses have been shown to
be able to extend Drosophila life span when the flies are cul-
tured at elevated temperatures [27-30].
Testing specific genes by overexpression in transgenic flies is
a candidate gene approach, meaning that the investigator
must make an educated guess as to which genes are worth
assaying by this relatively labor-intensive method. Recently
genetic methods have been developed that allow for the effi-
cient overexpression of random genes in Drosophila. P type
transposable elements have been engineered to have tran-
scriptional promoters directed out through the end of the
element [31,32]. These elements will often insert upstream of
gene coding regions, causing overexpression of the gene and
mutant phenotypes. The PdL P element contains an out-
wardly directed tet-on promoter [33,34]. The transcription of
this promoter is activated upon feeding the fly doxycycline,
leading to conditional gene overexpression and conditional
mutations. Conditional gene overexpression mutations have
several potential advantages for study of aging and life span.
By waiting until flies are young adults to activate gene overex-
pression, effects can be identified that are specific to adult
aging. The system also provides powerful controls for
genetic background effects, because control (no DOX) and
over-expressing (+DOX) flies have identical genetic back-
grounds and therefore any differences in life span must be
due to DOX administration and gene overexpression. The
PdL system allows the investigator to search for genes that
can increase life span without having to guess ahead of time
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potential to identify genes and pathways not previously
known or suspected to be involved in life span regulation.
Results 
In the rtTA transgenic construct the powerful and tissue-
general actin5C promoter drives expression of the rtTA tran-
scriptional transactivator [33]. When flies are fed
doxycycline, rtTA binds to target sequences in the synthetic
tet-on promoter in the PdL P element. This outwardly-
directed promoter often causes overexpression of genes near
the PdL insertion site and yields various mutant phenotypes
[34].  PdL is 8.4 kilobases (kb) long and contains the P
element inverted repeats, the mini-white+ transformation
marker gene, and the 500 base-pair (bp) tet-on promoter
directed out through the 3 end of the element. The tet-on
promoter contains no open reading frame (ORF) or transla-
tion initiation sequences. Therefore PdL must insert
upstream of an endogenous translation intiation site (ATG)
to cause overexpression of a protein. The transcripts initi-
ated within PdL will therefore contain 280 bp of 5 untrans-
lated sequence derived from PdL itself. 
To search for genes that might extend life span, new inser-
tions of PdL were created on the second and third chromo-
somes by appropriate crosses to a strain expressing P
element transposase (Figure 1). Approximately 10,000
males bearing a new PdL insert and an rtTA transcriptional
transactivator insertion were generated. The males were
generated in eight staggered groups, each of around 1,200
individuals. In an attempt to increase the variety of muta-
tions identified, two different rtTA insertion strains were
used. The first six cohorts of males contained an insertion of
the rtTA construct called rtTA(3)E2 that is associated with
moderate levels of target-gene expression and low levels of
leaky expression in the absence of DOX [33]. The last two
cohorts of males contained an rtTA insertion called
rtTA(3)M1 which is associated with a high level of target-
gene expression and greater leaky expression. To obtain
adult flies of defined age, the second cross was cultured at
25°C in urine specimen bottles (Figure 1). Prior to eclosion
of the majority of pupae, bottles were cleared of adults and
flies were allowed to emerge over the next 48 hours. The
majority of the males will have mated during this time. The
males only were then removed and were designated 1 day
old, and were maintained at 25°C at 40 per vial in culture
vials with food supplemented with 250  g/ml DOX, and
passaged to new vials every 48 hours. The expectation was
that some of these flies might live longer due to the overex-
pression of a beneficial gene. For the first four cohorts, at
approximately 30% survival of the cohort, each of the males
was individually mated with four third-chromosome bal-
ancer stock virgin females. This was so that a stable line
could be recovered later if that fly was found to be one of the
longest lived. Only about 21% of these males were found to
be fertile, meaning that there was selection for males that
maintained fertility during aging. After 4 days, the fertile
males were removed from the crosses, placed in individual
numbered vials, and passaged every two days until they were
all dead. For the rest of the cohorts the males were mated at
approximately 65% survival of the cohort, which increased
the frequency of fertile males to about 32%. Stable lines were
recovered for the approximately 1.4% longest-lived flies from
each cohort. These 144 lines should therefore be enriched for
ones in which PdL is causing overexpression of a gene with a
benefit for life span. In addition, lines in which PdL causes
overexpression of a gene with large negative effects on life
span should have been eliminated by this step.
Each of the 144 new PdL insertion lines was crossed to the
appropriate rtTA chromosome strain, and males containing
both constructs were assayed in large cohorts (around 400
flies) for doxycycline-dependent effects on life span
(Figure 2). The mean life spans of the different strains in the
absence of DOX varied greatly, from 40 to 84 days. Both
increases and decreases were observed in the presence of
DOX. For the 110 lines tested with rtTA(3)E2 there was an
average 1.8% increase in the presence of DOX (Figure 2a),
and for the 34 lines tested with rtTA(3)M1 an average 3.0%
increase in the presence of DOX (Figure 2b), consistent with
previous results that DOX itself has little to no effect on life
span. However, several lines were identified where there was
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Figure 1
Genetic crossing strategy. The starting PdL insertion on the X
chromosome PdL(X)A was mobilized using the  2-3 transposase source
to generate approximately 10,000 new PdL insertions on the second and
third chromosomes. Chromosomes potentially bearing new PdL insertions
are indicated by asterisks and were recovered in males that also
contained an rtTA transactivator construct. The males were allowed to
age in the presence of DOX in staggered cohorts of approximately 1,200
each and were individually mated to balancer virgins. Stable PdL insertion
lines were recovered for the longest-lived (approximately 1.4% of the
males in each cohort). A total of 110 lines were identified using rtTA
insertion rtTA(3)E2, and 34 lines with insertion rtTA(3)M1.
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xa significantly greater than average increase in life span in
the presence of DOX. To confirm these results, these lines
were assayed one or more additional times (Table 1). As a
control, Oregon-R wild-type flies were repeatedly crossed to
the rtTA strains and assayed for life span in parallel. The
Oregon-R controls exhibited changes in life span from
-5.14% to +4.71%, with an average change of +0.45%. In con-
trast, six PdL lines were found to yield significant and repro-
ducible increases in life span in the presence of DOX,
ranging from 5 to 17%. 
Line PdL(3)3E36 was associated with the largest increase in
life span (average 12%) (Table 1). The PdL insert in this line
was located in the large first intron of the encore gene [35],
with the promoter oriented in the sense direction
(Figure 3a). PdL caused the expression of a pair of approxi-
mately 1.4 kb transcripts that contain a 44 amino acid ORF
identified by the Drosophila genome project as CG14975, as
determined by northern blot with a CG14975 probe. These
transcripts were not detected in the absence of DOX in the
adult males and this putative gene was named Red herring
(Rdh). Northern analysis using a probe from encore exon 3
indicated that levels of the normal sized encore transcript
were not detectably altered by DOX, as indicated by the
arrowhead (Figure 3a). However, DOX appeared to induce
expression of both larger and smaller RNAs containing
encore coding-region sequences, resulting in a smear of
hybridization in the upper part of the lane, as indicated by
the asterisk. Representative survival curves are presented
(Figure 3a).
Line  PdL(2)4G14 contains an insert at the 5 end of the
VhaSFD gene, encoding the vacuolar proton pump ATPase
(H+-ATPase) SFD subunit [36]. DOX caused an approxi-
mately fourfold overexpression of the VhaSFD transcript
and an average 8% increase in life span (Figure 3b). Repre-
sentative survival curves for the PdL(2)4G14 line are pre-
sented (Figure 3b). Line PdL(3)2C33 contains an insert at
the 5 end of a gene with homology to a maltose permease
from  Bacillus stearothermophilus [37], which was named
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Figure 2
Life-span assay of new PdL insertion lines. The new PdL insertion lines were crossed to the appropriate rtTA insertion line, and male progeny were assayed
for life span in the presence (+DOX) and absence of DOX (-DOX). Each line is represented by a pair of bars, black bars for -DOX and white bars for
+DOX. (a) Lines crossed to rtTA(3)E2. The average life span -DOX was 64.7 days and the average +DOX was 65.9 days, for an average increase of 1.8%.
(b) Lines crossed to rtTA(3)M1. The average life span -DOX was 59.4 days and the average +DOX was 61.2 days for an average increase of 3.0%.
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(b)Sugar baby (Figure 3c). DOX caused an approximately 8.5-
fold overexpression of the Sugar baby transcript, and was
associated with an average 6% increase in life span.
Three genes with previously characterized mutant phenotypes
were also identified by PdL insertions. Line PdL(3)8S64 con-
tained an insert at the 5 end of the filamin gene ‘A’ transcript
(Figure 3d). Filamin is an actin-binding protein involved in
cytokinesis and ring canal formation [38,39]. filamin A was
overexpressed approximately fivefold in the presence of
DOX and associated with an average 8.5% increase in life
span. Expression of the filamin ‘B’ transcript was not
detectably altered. Line PdL(3)8S25 contained an insert at
the 5 end of the ‘B’ transcript of the four wheel drive (fwd)
gene (Figure 3e). fwd encodes a 1-phosphatidylinositol
4-kinase (PI 4-kinase) that regulates actin organization and
ring canal formation during germline cytokinesis [40]. fwd B
was overexpressed approximately 10-fold and associated
with an average 8% increase in life span. Finally, line
PdL(3)8R128 had an insert at the 5 end of the CTP:phos-
phocholine cytidylyltransferase 1 (Cct1) gene (Figure 3f).
Cct1 encodes a homolog of the rate-limiting enzyme in phos-
phatidylcholine biosynthesis [41]. Cct1 was overexpressed
approximately 1.7-fold and was associated with an average
7% increase in life span.
Discussion 
The genetic screen described here had several unusual
aspects, and the potential to identify a novel set of genes
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Table 1
PdL lines
Life-span phenotype*
Line name   Gene (enzyme) -DOX +DOX % Change (p) Date of assay
PdL lines crossed to rtTA(3)E2
PdL(3)3E36 Red herring/encore 60.42 0.920 64.34 0.864 +6.50 (0.0021) 7 October 1999
55.20 0.729 64.55 0.757 +16.95 (<0.0001) 6 July 1999
66.91 0.980 75.59 0.910 +13.00 (<0.0001) 14 February 2001
56.56 0.709 62.44 0.854 +10.38 (<0.0001) 7 August 2001
PdL(2)4G14 VhaSFD 76.05 1.039 82.71 1.088 +8.75 (<0.0001) 14 November 2000
69.28 1.077 76.24 1.538 +10.6 (0.0002) 18 July 2000
73.79 1.410 77.67 1.251 +5.27 (0.0404) 6 March 2001
55.40 0.810 59.34 0.887 +7.11 (0.0011) 21 August 2001
PdL(3)2C33 Sugar baby CG7334 73.91 1.501 80.32 1.392 +8.67 (0.0019) 15 November 2000
71.75 1.105 77.74 1.169 +8.35 (0.0002) 3 July 2000
68.99 1.100 72.22 1.034 +4.68 (0.0329) 6 March 2001
56.77 0.950 57.68 0.617 +1.59 (0.4241) 7 August 2001
Oregon-R 62.70 0.963 63.81 1.299 +1.76 (0.4954) 12 August 2001
Oregon-R 68.20 0.978 71.41 1.255 +4.71 (0.0438) 28 September 2000
Oregon-R 71.27 1.407 72.46 1.247 +1.66 (0.5278) 11 July 2000
Oregon-R 76.14 1.498 74.45 1.492 -2.23 (0.4236) 16 May 2000
Oregon-R 68.84 0.903 65.30 1.175 -5.14 (0.0176) 7 October 1999
PdL lines crossed to rtTA(3)M1
PdL(3)8S64 filamin 58.87 1.295 64.11 1.066 +8.76 (0.0020) 13 December 2000
56.00 1.202 60.68 1.103 +8.37 (0.0044) 3 May 2001
PdL(3)8S25 fwd  58.90 0.868 62.99 0.912 +6.93 (0.0013) 22 December 2000
(1-phosphatidylinositol 56.25 0.940 61.31 1.028 +9.00 (0.0003) 3 May 2001
4-kinase)
PdL(3)8R128 Cct1 59.68 1.192 64.34 1.052 +7.80 (0.0035) 27 February 2001
(cholinephosphate 56.54 0.789 59.85 0.852 +5.93 (0.0041) 10 July 2001
cytidylyltransferase)
Oregon-R 60.44 1.296 61.61 1.350 -1.96 (0.5337) 13 July 2001
Oregon-R 65.79 1.009 68.68 0.819 +4.39 (0.0266) 2 May 2001
Oregon-R 65.45 1.304 66.93 1.091 +2.20 (0.3824) 30 November 2000
*Mean life span  SEM, p-value for unpaired, two-sided t-test in parentheses.involved in life-span regulation. First, the screen was
designed to identify positive regulators of life span, that is,
genes that will increase life span when overexpressed. Most
genetic screens for life-span regulators in Drosophila and
other organisms, such as C. elegans, have involved loss-of-
function mutations and therefore have identified negative
regulators of life span [14,15,42,43]. Second, mutants were
identified on the basis of the phenotype of increased life
span under normal conditions, as opposed to some surrogate
phenotype expected to correlate with life span, such as
increased stress resistance. Because the PdL mutations gen-
erated here were screened directly for extended life span
under normal conditions, the screen had the potential to
identify genes and pathways not previously suspected to
have a role in aging and life-span regulation.
Results were reported recently for a screen for positive reg-
ulators of life span using a different P-element-based gene
overexpression strategy [29]. In that study a heat-stress
inducible system was used, and lines were screened for life
span at the moderate heat stress condition of 30°C. Several
genes were identified that increased survival when overex-
pressed, including genes involved in heat stress and oxida-
tive stress responses. It is interesting to note that there is no
overlap with the genes identified here with PdL at 25°C.
This may be due to the small fraction of the genome that
has been tested so far, or it may indicate that different
mechanisms limit life span under normal and moderate
heat-stress conditions.
It is difficult to estimate the number of genes that were
tested in the PdL screen, but it is certain to have been only a
tiny fraction of the genome. In previous experiments
approximately 7% of PdL insertions were found to cause
lethal and visible phenotypes when the PdL promoter was
activated during larval and pupal development [34]. Seven
percent is certainly a large underestimate of the frequency at
which genes are overexpressed, as embryogenesis was not
tested, and not all genes will be lethal or have an obvious
visible phenotype when overexpressed. The original 10,000
PdL insertions generated here went through an initial
enrichment step of unknown efficiency, to yield the 144 lines
that were tested in large cohorts. Lines in which a gene was
overexpressed that had a positive effect on life span should
have been enriched in the final 144 lines, whereas ones with
a significant negative effect should have been eliminated.
The enrichment step appears to have been at least partially
successful, as the largest negative effect on life span
observed among the 144 lines tested was -7.5%, and PdL is
known to be able to create mutations with negative effects of
up to -30% [34]. The molecular characterization of the
mutations suggests a low frequency of false positives. If the
six PdL insertion strains were a random set, then PdL would
be expected to sometimes be in the wrong orientation
and/or downstream of the ATG translation start. However,
all six lines were found to have PdL insertions at the 5 end
of a gene and oriented in the sense direction, and in all six
lines a transcript was overexpressed that was expected to
contain a complete ORF. 
The magnitude of life-span increases caused by the PdL
mutations was generally small, ranging from 5 to 17%. This
is in contrast to overexpression of SOD genes or certain
single gene mutations such as mth, where life-span increases
range from 20 to 50% [14,23-25]. There are at least two pos-
sible reasons for the relatively small life span increases
observed here. First, as only a fraction of the genome has
been tested, it may be that genes with larger effects exist but
have not yet been identified. Second, the tet-on system is
sometimes leaky, meaning that at certain genomic locations
there can be significant expression of the tet-on promoter in
the absence of DOX [33]. It is possible that in some of the
lines the increase in life span between -DOX and +DOX is
reduced because there is already some gene overexpression
and life-span extension in the -DOX flies. Such a line might
be expected to have an unusually high -DOX life span rela-
tive to the other lines, and it is notable that this appears to
be the case for the lines bearing mutations in the VhaSFD
and Sugar baby genes. When this difference is included in
the calculations, the life span increases for VhaSFD and
Sugar baby are approximately 20% and 17%, respectively.
The largest average increase in life span caused by DOX
(12%) was obtained for the PdL(2)3E36 insertion in the large
first intron of the encore gene. A pair of approximately 1.4 kb
transcripts was expressed containing a 44 amino acid ORF
with no detectable homologies. While there are a number of
Drosophila genes encoding functional ORFs of this size, it is
also possible that these transcripts do not encode a func-
tional protein but rather function at the RNA level to affect
life span. There are no cDNAs in the databases containing
these intronic sequences, and we were unable to detect these
transcripts in wild-type adult males using northern blots.
The data suggest that these transcripts are not expressed
under normal conditions, or are expressed at very low levels.
Further experiments will be required to determine the mech-
anism of life-span extension in this line, and the elusive
nature of the intronic gene suggested the name Red herring.
The northern analyses also indicated induction of a small
amount of a large transcript containing the encore coding
region. Therefore it is also possible that the life span exten-
sion in this line is caused by an increase in the expression of
encore. encore is a member of a novel family of proteins with
multiple functions during Drosophila oogenesis [44].
Two of the genes identified appear to be involved in mem-
brane transport. The VhaSFD gene encodes the Drosophila
homolog of the vacuolar H+-ATPase SFD subunit. The vac-
uolar ATPase is an ATP-driven proton pump found in the
endomembranes of eukaryotic cells [36,45-47]. It is com-
posed of a cytoplasmic ATPase domain called V1 that con-
tains VhaSFD and other subunits, and a multisubunit
R8.6 Genome Biology 2003, Volume 4, Issue 2, Article R8 Landis et al. http://genomebiology.com/2003/4/2/R8
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Figure 3 (See parts b-f on the following pages)
Characterization of new PdL mutations. (a) PdL(3)3E36 (Red herring and encore (enc)); (b) PdL(2)4G14 (VhaSFD); (c) PdL(3)2C33 (Sugar baby);
(d) PdL(3)8S64 (filamin); (e) PdL(3)8S25 (four wheel drive (fwd)); (f) PdL(3)8R128 (CTP:phosphocholine cytidylyltransferase-1 (Cct1)). The molecular
organization of each mutated gene is diagrammed. The PdL insertion is indicated by a triangle, with an arrow indicating the direction of transcription of
the PdL tet-on promoter. Transcript start sites and ATG translation start codons are marked by arrows. The location of PdL insertions, transcription
start sites, ATG translation start sites, and transcript termination sites are indicated by genomic scaffold numbers. mRNA was isolated from whole adult
male flies cultured  DOX and analyzed by northern blot. Hybridization with ribosomal protein gene Rp49 probe was used as a loading control. The
locations of gene-specific DNA probes used for northern analyses are indicated. Transcript sizes were estimated using RNA markers run in adjacent
lanes (data not shown). Two representative survival curves are presented for each line. 
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2 1 22 23 24 25 26 27 28 29 21 0 2membrane-channel component called V0. The vacuolar
ATPase is involved in the acidification and energization of
organelles such as Golgi-derived vesicles, clathrin-coated vesi-
cles, synaptic vesicles and lysosomes. The proton pumping is
required for processes such as protein trafficking, receptor-
mediated endocytosis, neurotransmitter release and intracel-
lular pH regulation and waste management. The free
membrane V0 domain has also been implicated in membrane
fusion events. In higher organisms the vacuolar H+-ATPase is
also found in the plasma membrane of specialized epithelial
cells where it functions in bulk transport. In Drosophila this is
the Malpighian (or renal) tubule. The VhaSFD subunit is
required for the ATPase activity and assembly of the vacuolar
H+-ATPase and may function as a dissociable regulatory
subunit. Therefore, overexpression of VhaSFD may affect life
span by increasing activity of the vacuolar H+-ATPase.
The Sugar baby gene is related to a maltose permease from
Bacillus stearothermophilus [37], suggesting that it may
function in transport of maltose or other sugars across a
membrane. Recently, loss-of-function mutations in another
putative membrane transporter, Indy, have been found to
increase life span [15]. It is possible that overexpression of
the putative transporter encoded by Sugar baby could
increase life span by increasing uptake of a particular sugar
and altering energy metabolism pathways.
Filamin is an actin-binding protein with a homolog in
humans called actin-binding protein 280 (ABP280) [38,39].
Filamin binds to several cell-membrane proteins and inter-
cellular ligands involved in signal transduction, and appears
to act as a downstream effector in remodeling of the actin
cytoskeleton. During Drosophila oogenesis, filamin localizes
to the ring canals, which are membrane-associated actin
cytoskeletal structures that create intercellular bridges
between germline cells. Loss-of-function mutations of
filamin disrupt the normal function of these actin cytoskele-
tal structures. Filamin has several additional interactions
with potential relevance to aging studies. Presenilins are
membrane proteins found in both humans and Drosophila,
and mutations in human presenilins are associated with
early onset familial Alzheimer’s disease (FAD) [48].
Drosophila filamin binds to both Drosophila and human
presenilins, and filamin interacts genetically with presenilin
in Drosophila [49]. Dominant adult phenotypes produced in
Drosophila by overexpression of presenilin can be sup-
pressed by overexpression of filamin. Filamin also interacts
specifically with Drosophila Toll and Tube proteins [50].
Toll and Tube are members of a signal transduction pathway
that activates the Rel transcription factor Dorsal and is
involved in developmental patterning and in the adult
immune response. Several of the immune-response genes
regulated by Rel transcription factors are dramatically
R8.10 Genome Biology 2003, Volume 4, Issue 2, Article R8 Landis et al. http://genomebiology.com/2003/4/2/R8
Genome Biology 2003, 4:R8
Figure 3 (See legend on page 7)
−DOX             +DOX
1x        2x
 −DOX             +DOX
Oregon-R
1x        2x 1x        2x 1x        2x
Genomic scaffold AE003472.1
Cct1
ATG
11387 16096
Exon 1 Exon 2 Exon 3 Exon 4
17928 11405
Exon 4 probe
2/27/200
0
20
40
60
80
100
+DOX
−DOX
7/10/200
0
20
40
60
80
100
+DOX
−DOX
PdL(3)8R128
Cct1
Cct1 exon 4 probe
Rp49 probe
(f)
Day
2 1 22 23 24 25 26 27 28 29 21 0 2
Day
2 1 22 23 24 25 26 27 28 29 21 0 2induced during Drosophila aging (G.L., J. Carrick and J.T.,
unpublished data).
fwd encodes a phosphatidylinositol 4-kinase (PI 4-kinase)
that converts phosphatidylinositol (PI) to phosphatidylinosi-
tol 4-phosphate (PIP) [40]. This is the first step in the synthe-
sis of the key regulatory membrane phospholipid PIP2, which
is generated from PIP by a PI 4,5-kinase. PIP2 interacts
directly with a number of proteins, regulating both their sub-
cellular localization and their activity. Data from yeast and
mammalian systems implicates homologous PI 4-kinases and
PIP2 in regulation of secretion and membrane vesicle traf-
ficking [51,52]. In Drosophila, fwd gene function is required
for the formation of ring canals and cytoplasmic bridges
during cytokinesis in male meiosis. PIP2 is also the precur-
sor to the important second messengers PIP3 and diacylglyc-
erol. PIP3 is involved in the insulin-like signaling pathway
that affects life span in Drosophila and C. elegans [53], and
it will be of interest to determine if fwd overexpression is
somehow affecting this pathway.
CTP:phosphocholine cytidylyltransferase (Cct) catalyzes the
conversion of phosphocholine to CDP-choline and is the
rate-limiting enzyme in the phosphatidylcholine biosyn-
thetic pathway [41]. Phosphatidylcholine is a major mem-
brane phospholipid and is a precursor to second messengers
involved in signal transduction at the membrane, including
the PIP, PIP2 and PIP3 discussed above. There are two
genes encoding Cct in Drosophila (Cct1 and  Cct2), and
mutations in the Cct1 gene disrupt patterning during oogen-
esis (T. Gupta and T. Schupbach, personal communication).
Overexpression of Cct1 might affect life span by increasing
synthesis of phosphatidylcholine and altering membrane
structure and/or phospholipid signaling pathways.
It is striking that most of the genes identified in this screen
as positive regulators of Drosophila life span are implicated
in functions at the membrane, including regulation of trans-
port, phospholipid metabolism, signal transduction and
actin cytoskeleton organization. It is tempting to speculate
that some of these genes may be acting in the same
pathway(s) for life-span regulation. For example, both
filamin and fwd are involved in the function of ring canals,
which are membrane-associated actin cytoskeletal structures
that create intercellular bridges between germline cells
during early mitotic divisions [38-40]. encore is also
required for normal early mitotic division of the germline
cells [44]. In C. elegans, germline cells have recently been
shown to send signals that regulate life span of the adult
organism [54-56], and it will be of interest to determine if
any of the genes identified here increase life span through
effects on the germline. Both fwd and Cct1 are involved in
phospholipid metabolism, and phospholipid signaling
pathways are implicated in life-span regulation in Drosophila
and other organisms [53]. The conserved insulin-like life-span
regulatory pathway includes a PI 3-kinase that converts PIP2
into PIP3. The enzymes encoded by fwd and Cct1 are both
in the biosynthetic pathway for PIP2 and therefore might
affect the insulin-like pathway by altering the availability of
this substrate. Further experiments will be required to
confirm the role of these genes in life-span regulation, and to
determine their interactions with each other and in known
or novel life-span regulatory pathways.
Materials and methods 
Drosophila strains 
All D. melanogaster strains are as described [33,34,57,58].
Drosophila culture and life-span assays 
Drosophila were cultured on standard agar/molasses/corn
meal/yeast media [59]. To obtain adult flies of defined age,
the indicated PdL lines and Oregon-R control strain were
crossed to an rtTA stock and cultured at 25°C in urine speci-
men bottles. Prior to eclosion of the majority of pupae, bottles
were cleared of adults and newly eclosed flies were allowed to
emerge over the next 48 h. The majority of the males will
have mated during this time. The males only were then
removed and were designated 1 day old, and were maintained
at 25°C at 40 per vial in culture vials with food. At 4 days of
age the males were split into control and experimental groups
of 200 males each, with experimentals (+DOX) placed on
culture media supplemented with 250  g/ml DOX. Dead flies
were counted at each passage, and the number of vials was
progressively reduced to maintain approximately 40 flies per
vial. To calculate mean life spans for the experimental
(+DOX) and control (-DOX) cohorts, each fly’s life span was
tabulated and their life spans were averaged and the standard
error of the mean (SEM) calculated. Statistical significance of
differences in mean life span was calculated for each experi-
ment using unpaired two-sided t tests.
ANOVA 
Two-way analysis of variance (ANOVA) was performed for
each life-span dataset. The first dataset was the 110 lines
crossed to rtTA(3)E2 (Figure 2a). Sources of variance were
line, treatment (DOX), and line x treatment. Results are pre-
sented in Table 2. A P-value   0.05 was considered statisti-
cally significant. The significant line x treatment interaction
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Table 2
ANOVA results for 110 lines crossed to rtTA(3)E2
Source Degrees Mean  square Fp
of freedom
Line 109 30,407.071 134.854 < 0.001
Treatment 1 19,763.341 87.650 < 0.001
Line x treatment 109 720.007 3.193 < 0.001
Error 40,129 225.481for dataset 1 indicated that DOX affects life span only in
certain lines. The significance and 95% confidence interval
were calculated for each line with experiment-wise error rate
for multiple comparisons reduced using the Bonferroni
method (see supplemenetary table in Additional data files).
DOX decreased life span in 6 lines and increased it in 34
lines. The second dataset was the 34 lines crossed to
rtTA(3)M1 (Figure 2b). Results were line F = 57.168,
p < 0.001; treatment F = 48.131, p < 0.001; line x treatment
F = 1.898, p = 0.001. The significant line x treatment inter-
action again indicates that DOX affects life span only in
certain lines. The significance and 95% confidence interval
were calculated for each line, with experiment-wise error
rate reduced using the Bonferroni method (see supplemen-
tary table in Additional data files). DOX decreased life span
in one line, and increased it in seven lines. 
Each line in which DOX increased life span was crossed to
the appropriate rtTA strain and assayed one to three addi-
tional times. For six lines there was a reproducible increase
in life span with DOX (Table 1). As an additional control,
Oregon-R wild-type was repeatedly crossed to rtTA(3)E3
and to rtTA(3)M1 strains and assayed for life span in the
presence or absence of DOX. These datasets were analyzed
using two-way ANOVA with date of assay, treatment (DOX),
and date x treatment as the sources of variance. Dataset 3
was the four independent assays of line PdL(3)3E36 (Red
herring/encore) (Table 1). Results were date F = 100.690,
p < 0.001; treatment F = 129.780, p < 0.001; and date x
treatment F = 5.387, p = 0.001. Dataset 4 was the four inde-
pendent assays of line PdL(2)4G14 (VhaSFD). Results were
date  F = 145.348, p < 0.001, treatment F = 43.294,
p < 0.001, date x treatment F = 1.057, p = 0.366. Dataset 5
was the four independent assays of line PdL(3)2C33 (Sugar
baby). Results were date F = 121.648, p   0.001; treatment
F = 24.728, p    0.001; date x treatment F = 2.283, p =
0.077. Dataset 6 was the five independent assays of Oregon-
R crossed to rtTA(3)E2 (Table 2). Results were date F =
28.171, p < 0.001, treatment F = 0.005, p = 0.944, date x
treatment F = 2.313, p = 0.056. Dataset 7 was the two inde-
pendent assays of line PdL(3)8S64 (filamin). Results were
date F = 7.192, p = 0.007, treatment F = 17.871, p < 0.001,
date x treatment F = 0.057, p = 0.812. Dataset 8 was the two
independent assays of line PdL(3)8S25 (fwd). Results were
date F = 5.319, p = 0.021, treatment F = 23.784, p < 0.001,
date x treatment F = 0.271, p = 0.603. Dataset 9 was the two
independent assays of line PdL(3)8R128 (Cct1). Results were
date F = 15.405, p < 0.001, treatment F = 17.177, p < 0.001,
date x treatment F = 0.455, p = 0.500. Dataset 10 was the
three independent assays of Oregon-R crossed to rtTA(3)M1.
Results were date F = 16.611, p < 0.001, treatment F = 3.777,
p = 0.052, date x treatment F = 0.315, p = 0.730.
Southern analysis of PdL copy number 
DNA was isolated from PdL lines and restriction digested
with  XbaI,  HindIII,  PstI and TaqI in separate reactions.
DNA was transferred to a Southern blot and hybridized with
a radiolabeled 172 bp fragment from the 3 P end of
PdL. This probe fragment was generated by PCR amplifica-
tion with primers located within the 3 P end, IRREV
(ATGATGAAATAACATAAGGTGGTCCCG) and P3MCSREV
(ATGAGTTAATTCAAACCCCACGGACAT).
Inverse PCR amplification of PdL flanking sequences 
Protocols were as previously described [60,61]. Briefly,
DNA equivalent to one fly was restriction digested with
TaqI. The DNA was extracted with phenol/chloroform,
precipitated with ethanol, resuspended and treated with T4
ligase overnight at 16°C. PCR amplification was performed
using primers Pry1 (CCTTAGCATGTC-
CGTGGGGTTTGAAT) and IR (CGGGACCACCTTATGT-
TATTTCATCATG) located in the 3 P end. PCR protocol
was as follows: step 1, 95°C for 5 min; step 2, 95°C for 30
sec; step 3, 51°C for 1 min; step 4, 72°C for 1 min; step 5,
repeat steps 2-4 40 times; step 6, 72°C for 10 min. The PCR
product was subcloned into the pCR2.1-TOPO cloning
vector (Invitrogen). Dideoxy sequencing was carried out
using the Sequenase version 2.0 DNA sequencing kit (US
Biochemical) and the T7 and M13 reverse sequencing
primers. Each inverse PCR product will contain 284 bp of
3 P-element sequences. The sizes of the products were:
PdL(3)3E36 (Red herring/encore) 534 bp; PdL(2)4G14
(VhaSFD) 465 bp; PdL(3)2C33 (Sugar baby) 464 bp;
PdL(3)8S64 (filamin) 362 bp; PdL(3)8S25 (fwd) 345 bp;
PdL(3)8R128 (Cct1) 298 bp.
DNA sequence analyses 
PdL-flanking DNA sequences were used to query GenBank
databases using BLASTN with default settings as provided at
the National Center for Biotechnology Information (NCBI)
website [62]. Genomic scaffold sequences and numbering
and ORF designations are according to the NCBI databases
and Drosophila genome sequence [63].
Northern blot analyses 
RNA was isolated from adult Drosophila  using the
RNAqueous kit (Ambion), fractionated on 1.0% agarose
gels and transferred to GeneScreen membranes
(DuPont/NEN). 1x = 4  g, and 2x = 8  g, except for the
analysis of Sugar baby where 1x = 8  g. The DNA probe
for exon 5 of the fwd gene was generated by PCR amplifi-
cation from Drosophila genomic DNA using primers
FWDFWD (TGCTTCCTCCATTTGGCGAAC) and FWDREV
(ATCATCTGTGGCTCAGAGTCG). The probe for exon 2 of
the VhaSFD gene was generated using primers VhaFWD
(CCAGCTGATCCTTCAGGAACTGC) and VhaREV
(ACCAGGACGATCAACTGGGCTTC). The probe for exon
15 of the filamin A gene was generated using primers FIL-
AMINAFWD (GCCAATGTAGGCCTTCTTCAG) and FIL-
AMINAREV (ATCCATGCCATCCACGTCAAG). The probe
for exon 1 of the CG1049 gene was generated using
primers CG1049EX1FWD (AGTTGTGTTTGTGTCCGACG)
R8.12 Genome Biology 2003, Volume 4, Issue 2, Article R8 Landis et al. http://genomebiology.com/2003/4/2/R8
Genome Biology 2003, 4:R8and CG1049EX1REV (ATAAACAGAGCAGAGCAGAGC).
The probe for exon 4 of the CG1049 gene was generated
using primers CG1049EX4FWD (TCTGTCCGAT-
GAATTCATCGCC) and CG1049EX4REV (ATGATTC-
AGGTTCTCACGTCCG). The CG14975 ORF probe was
generated using primers CG14975FWD (TCAGCCGAGA-
GATTCTAGAGAG) and CG14975REV (CATCGAC-
CATTGTTCTCTCTCC). The 3E36 intergenic region probe
was generated using primers 3E36-140120FWD (TTTC-
CATTTCCCTTCCACTGCC) and 3E36-1406038REV
(TTACAGCTGCTCACTCACTCAC). The probe for exon 3 of
the encore gene was generated using primers ENCFWD
(AATGAAGCGGAGTTCCCAAAGC) and ENCREV
(ATAAAGCCCGAGGTGTTGTTGC). The probe for exon 3
of the Hr39 gene was generated using primers Hr39FWD
(ACATGTCCAGCATCAAAGCGG) and Hr39REV (TATCG-
GTTGTAGTGCGCAGAC). The 8R96 intergenic region
probe was generated using primers 8R96-225683FWD
(CAAGTGGGCTCCATAATAGC) and 8R96-226069REV
(TGGAGCTCTCGGTCTGTTAG). The probe for exon 4 of
the  CG8677 gene was generated using primers
CG8677FWD (ATCCGTACCAGTGGCTAAAAGG) and
CG8677REV (TTCTTCAACAGCACCACTCGTC). The
loading control was ribosomal protein gene Rp49 [64].
DNA probes were 32P-labeled using the Prime-It II DNA
labeling kit (Stratagene). Hybridization was carried out in
Church-Gilbert solution at 65°C overnight. Hybridization
signals were visualized and quantitated using the phos-
phoimager and ImageQuant software (Molecular Dynam-
ics), and exposure times were 4 days. Transcript size was
determined by comparison with 1 kb RNA ladder (Gibco-
BRL) according to the manufacturer’s instructions.
Relative RNA levels and the fold induction of transcripts in the
presence of DOX were estimated as follows. A box was drawn
around the band for each gene transcript and intensity mea-
sured in arbitrary units using the phosphoimager and Image-
Quant. An equal sized box was drawn around a region of the
lane containing no bands and that value was subtracted as
background.  Rp49 loading control was quantitated in the
same way for each lane. Each Rp49 intensity value was
divided by the median Rp49 intensity value to generate a
loading correction factor for each lane. A normalized intensity
value for each gene transcript was then calculated by multiply-
ing by the Rp49 correction factor for that lane. This quantita-
tion was done twice for each phosphoimage. The 1x and 2x
northern lanes for each RNA sample were quantitated and the
numbers were averaged. The resulting relative expression
levels are presented in arbitrary units  standard deviation
(SD). VhaSFD: -DOX = 4.8 1.2; +DOX = 20 5.5; fold induc-
tion approximately 4. Sugar baby: -DOX = 1.5 0.5; +DOX =
12.8 2.4; fold induction approximately 8.5. filamin: -DOX =
59 11; +DOX = 318 64; fold induction approximately 5.
fwd: -DOX = 240 7; +DOX = 2,303 28; fold induction
approximately 10. Cct: -DOX = 2.3 0.4; +DOX = 4.0 0.2;
fold induction approximately 1.7.
Additional data files 
A table showing the calculation of 95% confidence intervals
for all the datasets is available with the online version of
this paper. 
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